相关实验视频
Updated: Jan 31, 2026

07:16
Isolation of Cancer Stem Cells From Human Prostate Cancer Samples
Published on: March 14, 2014
14.6K
高RMI1表达与癌细胞进展和前列腺癌的不良预后有关
Pengliang Shen1, Xiaosong Wang2, Xiaoting Yan1
1Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, Shanxi 030001, P.R. China.
Oncology reports
|January 30, 2026
概括
RecQ介导的基因组不稳定性1 (RMI1) 是前列腺癌 (PCa) 的新型预后生物标志物. 高RMI1表达表明生存率较差,并促进PCa细胞的增殖和迁移,这表明它是治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 前列腺癌 (PCa) 的进展与DNA复制压力和能量平衡有关.
- 在这些途径中识别预后生物标志物对于PCa诊断和治疗至关重要.
研究的目的:
- 确定新的DNA复制压力和与能量恒常相关的基因作为PCa的预后生物标志物.
- 调查已识别的生物标志物在PCa进展,免疫微环境和治疗反应中的作用.
主要方法:
- 来自公共数据集的转录和临床数据的分析.
- 使用RT-qPCR,西式涂抹,生存分析和功能测试的验证.
- 评估免疫微环境,突变状态和药物敏感性.
主要成果:
- 在PCa组织中,RecQ介导的基因组不稳定性1 (RMI1) 被确定为一个持续上调的基因.
- 高RMI1表达与较差的生存,晚期,TP53突变和免疫逃逸相关.
- 降低RMI1抑制了PCa细胞的增殖和迁移,而高RMI1预测了对义诺太干的耐药性.
结论:
- RMI1是PCa检测和患者分层的一个有前途的预后生物标志物.
- 通过促进增殖和迁移,RMI1可能会推动PCa的进展,这代表了一个潜在的治疗目标.
相关概念视频
mTOR Signaling and Cancer Progression
4.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.8K
Cancer
54.2K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
54.2K
Cancer Cell Migration through Invadopodia
3.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.3K
What is Cancer?
14.4K
Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
14.4K
Adaptive Mechanisms in Cancer Cells
7.1K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.1K
Cancer Stem Cells and Tumor Maintenance
6.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.0K

